Suppr超能文献

丙磺舒预处理后大鼠体内巴比妥透过血脑屏障的渗透率增加。

Increased penetration of barbital through the bloodbrain barrier in the rat after pretreatment with probenecid.

作者信息

Wahlström G

出版信息

Acta Pharmacol Toxicol (Copenh). 1978 Oct;43(4):260-5. doi: 10.1111/j.1600-0773.1978.tb02263.x.

Abstract

Some weak organic acids are eliminated from the brain by an acid transport system. The question arose is this system also used to transport drugs out of the brain? In that case probenecid pretreatment (100 mg/kg subcutaneously) should influence the induction time of a slightly lipid soluble barbiturate (barbital) which penetrates into the brain slowly, more than the induction time of a very lipid soluble barbiturate (hexobarbital). In the first experiment barbital (200 mg/kg) was given intraperitoneally and in the second experiment barbital (150 mg/kg) was infused intravenously during 10 min. In both experiments loss of righting reflex occurred more rapidly after pretreatment with probenecid compared with pretreatment with saline. Only in the second experiment did probenecid significantly increase the time during which the righting reflex was lost. In the next experiment hexobarbital was infused intravenously at a rate of 0.25 mg/kg/sec. until a burst suppression which lasted 1 sec. or more was seen in a concomitant EEG-record. When this "silent second" occurred the infusion was stopped and the ensuing anaesthesia times recorded. Probenecid had no effect on the induction when studied with this method, but the ensuing anaesthesia times were increased. The hypothesis of an acid transport system out of the brain was thus not refuted by these experimental results. Studies of brain concentrations of barbital also supported this finding. After 200 mg/kg intraperitoneally the concentration of barbital in the brain was higher after pretreatment with probenecid as compared to saline pretreated controls i.e. at times corresponding to the induction times in the in vivo experiments. No difference was found in the serum levels of barbital.

摘要

一些弱有机酸通过一种酸转运系统从大脑中被清除。问题在于该系统是否也用于将药物转运出大脑?如果是这样,丙磺舒预处理(皮下注射100mg/kg)应该对一种脂溶性稍低、缓慢渗透入大脑的巴比妥酸盐(巴比妥)的诱导时间影响更大,比对一种脂溶性非常高的巴比妥酸盐(己巴比妥)的诱导时间影响更大。在第一个实验中,腹腔注射巴比妥(200mg/kg),在第二个实验中,在10分钟内静脉输注巴比妥(150mg/kg)。在两个实验中,与用生理盐水预处理相比,用丙磺舒预处理后翻正反射消失得更快。仅在第二个实验中,丙磺舒显著延长了翻正反射消失的时间。在下一个实验中,以0.25mg/kg/秒的速率静脉输注己巴比妥,直到在同步脑电图记录中出现持续1秒或更长时间的爆发抑制。当出现这种“沉默期”时,停止输注并记录随后的麻醉时间。用这种方法研究时,丙磺舒对诱导没有影响,但随后的麻醉时间延长。因此,这些实验结果并未反驳存在大脑外酸转运系统的假说。对大脑中巴比妥浓度的研究也支持了这一发现。腹腔注射200mg/kg后,与生理盐水预处理的对照组相比,丙磺舒预处理后大脑中巴比妥的浓度更高,即在与体内实验诱导时间相对应的时间点。巴比妥的血清水平未发现差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验